A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)

NCT04742725 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

231

Enrollment

OTHER

Sponsor class

Conditions

Coronavirus Disease 2019 (COVID-19)

Interventions

DRUG: Placebo
DRUG: Prothione™ (6g)

Sponsor

Prothione, LLC